May 19th 2025
Deal includes 23andMe’s Biobank, Personal Genome Service, Total Health, and research services operations.
COVID-19 Vaccine Concerns Prompt Clinical Trial Transparency
September 20th 2020With all eyes on efforts to research and test potential vaccines and therapies to combat the coronavirus pandemic, fears about overly accelerated development programs has heightened demands for wider access to information on study protocols, statistical analysis plans, and early results.
The Cultural Deficit in the Pharma Industry in the Era of COVID-19
September 10th 2020Multicultural campaigns crafted for diverse populations are insufficiently funded and do not receive the same support as mainstream campaigns, writes Sheila Thorne. While there are plenty of people willing to partner with pharma on these campaigns, will the industry wake up to the changing world ahead?
The Teladoc-Livongo Merger: Life Science Manufacturers’ Darwinian Moment
September 8th 2020The recent merger of Teledoc and Livongo into a $38 billion titan proves that the market sees opportunity in health tech. Could it be an inflection point in our race towards a digital-first care model, or is this an experiment ahead of its time?